Virus-like particles induce robust human T-helper cell responses

European Journal of Immunology

Volumn 42, Issue 2, 2012, Pages 330-340

  Braun, Marion ^a   Jandus, Camilla ^b   Maurer, Patrik ^c   Hammann Haenni, Anya ^c   Schwarz, Katrin ^c   Bachmann, Martin F ^c   Speiser, Daniel E ^a   Romero, Pedro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

Cancer immunotherapy; Immunomonitoring; Melanoma; Th1; Virus like particles

Indexed keywords

CANCER VACCINE; CD40 LIGAND; GAMMA INTERFERON; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MELAN A; TUMOR NECROSIS FACTOR ALPHA; VIRUS LIKE PARTICLE VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; VACCINATION;

ADULT; AGED; ANTIBODY FORMATION; ANTIGENS, CD4; CANCER VACCINES; CELLS, CULTURED; FEMALE; HUMANS; MALE; MART-1 ANTIGEN; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PEPTIDE FRAGMENTS; SKIN NEOPLASMS; T-LYMPHOCYTES, HELPER-INDUCER; VIRION;

EID: 84856051431     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142064     Document Type: Article

References (33)

1. Gourley, T. S., Wherry, E. J., Masopust, D. and Ahmed, R., Generation and maintenance of immunological memory. Semin. Immunol. 2004. 16: 323-333.
2. Stavnezer, J., Immunoglobulin class switching. Curr. Opin. Immunol. 1996. 8: 199-205.
3. Keene, J. A. and Forman, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 1982. 155: 768-782.
4. Husmann, L. A. and Bevan, M. J., Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann. NY Acad. Sci. 1988. 532: 158-169.
5. Guerder, S. and Matzinger, P., A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 1992. 176: 553-564.
6. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
7. Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G. and Schoenberger, S. P., CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003. 421: 852-856.
8. Shedlock, D. J. and Shen, H., Requirement for CD4 T-cell help in generating functional CD8 T-cell memory. Science 2003. 300: 337-339.
9. Crotty, S., Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011. 29: 621-663.
10. Sallusto, F. and Lanzavecchia, A., Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 2009. 39: 2076-2082.
11. Jandus, C., Bioley, G., Dojcinovic, D., Derre, L., Baitsch, L., Wieckowski, S., Rufer, N. et al., Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Cancer Res. 2009. 69: 8085-8093.
12. Jennings, G. T. and Bachmann, M. F., The coming of age of virus-like particle vaccines. Biol. Chem. 2008. 389: 521-536.
13. Speiser, D. E., Schwarz, K., Baumgaertner, P., Manolova, V., Devevre, E., Sterry, W., Walden, P. et al., Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J. Immunother. 2010. 33: 848-858.
14. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H. and Zinkernagel, R. M., The influence of antigen organization on B-cell responsiveness. Science 1993. 262: 1448-1451.
15. Bachmann, M. F. and Jennings, G. T., Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 2010. 10: 787-796.
16. Kundig, T. M., Senti, G., Schnetzler, G., Wolf, C., Prinz Vavricka, B. M., Fulurija, A., Hennecke, F. et al., Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J. Allergy Clin. Immunol. 2006. 117: 1470-1476.
17. Chackerian, B., Lowy, D. R. and Schiller, J. T., Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 2001. 108: 415-423.
18. Zhang, L. F., Zhou, J., Chen, S., Cai, L. L., Bao, Q. Y., Zheng, F. Y., Lu, J. Q. et al., HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine 2000. 18: 1051-1058.
19. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kolsch, E. et al., Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 1995. 25: 823-829.
20. Kawano, Y., Noma, T. and Yata, J., Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J. Immunol. 1994. 153: 4948-4958.
21. Skvaril, F., IgG subclasses in viral infections. Monogr. Allergy 1986. 19: 134-143.
22. Aalberse, R. C., van der Gaag, R. and van Leeuwen, J., Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 1983. 130: 722-726.
23. Vos, Q., Lees, A., Wu, Z. Q., Snapper, C. M. and Mond, J. J., B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 2000. 176: 154-170.
24. Dintzis, R. Z., Vogelstein, B. and Dintzis, H. M., Specific cellular stimulation in the primary immune response: experimental test of a quantized model. Proc. Natl. Acad. Sci. USA 1982. 79: 884-888.
25. De Maziere, A. M., Muehlethaler, K., van Donselaar, E., Salvi, S., Davoust, J., Cerottini, J. C., Levy, F. et al., The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins. Traffic 2002. 3: 678-693.
26. Valmori, D., Souleimanian, N. E., Tosello, V., Bhardwaj, N., Adams, S., O'Neill, D., Pavlick, A. et al., Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proc. Natl. Acad. Sci. USA 2007. 104: 8947-8952.
27. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K., Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006. 212: 28-50.
28. Castellino, F., Huang, A. Y., Altan-Bonnet, G., Stoll, S., Scheinecker, C. and Germain, R. N., Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006. 440: 890-895.
29. Castellino, F. and Germain, R. N., Chemokine-guided CD4+ T-cell help enhances generation of IL-6RalphahighIL-7Ralpha high prememory CD8+ T cells. J. Immunol. 2007. 178: 778-787.
30. Bos, R. and Sherman, L. A., CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res. 2010. 70: 8368-8377.
31. Alexander-Miller, M. A., Leggatt, G. R., Sarin, A. and Berzofsky, J. A., Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 1996. 184: 485-492.
32. Jegerlehner, A., Tissot, A., Lechner, F., Sebbel, P., Erdmann, I., Kundig, T., Bachi, T. et al., A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B-cell responses. Vaccine 2002. 20: 3104-3112.
33. Chattopadhyay, P. K., Yu, J. and Roederer, M., Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat. Protoc. 2006. 1: 1-6.